The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2022 | The impact of RBPs in the development of hematological malignancies and bone marrow failure
Miguel Gallardo, PhD, Spanish National Cancer Research Center (CNIO), Madrid, Spain, discusses the impact of RNA binding proteins (RBPs) in the development and progression of various hematological malignancies. Dr Gallardo first highlights how the over-expression of RBPs, including hnRNP K, can promote hematopoietic stem cell exhaustion and bone marrow failure, and then goes on to discuss some ongoing research in the field. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
